| mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |